Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence

被引:53
作者
Tala-Heikkila, MM
Tuominen, JE
Tala, EOJ
机构
[1] Turku Univ, Dept Biomed, Turku, Finland
[2] Turku Univ, Cent Hosp, Dept Paediat, Turku, Finland
[3] Paimio Hosp, Dept Dis Chest, Pretila, Finland
关键词
D O I
10.1164/ajrccm.157.4.9706037
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Bacillus Calmette-Guerin (BCG) revaccination was discontinued in Finland in 1990. The objective of this study was to assess the impact of BCC revaccination of tuberculin-negative school-children in prevention of tuberculosis. The tuberculosis cases in 1990-1995 were calculated among age cohorts born 1979-1984 and no longer covered by the BCC revaccination program. Corresponding data were collected for comparison from the period of revaccination in 1980-1985 among age cohorts born in 1969-1974. The National Tuberculosis Register was reviewed in order to observe the tuberculosis trend since 1980 in the age groups of 10-14 and 15-19 yr. Three cases of tuberculosis have been registered among non-BCC-revaccinated children during 6 yr after discontinuation of the program, i.e., 2.23 cases (95% CI 0.72 to 6.90) per million person yr. The control group revealed five cases, 3.78 (95% CI 1.57 to 9.07) per million person yr. The relative risk of tuberculosis in non-BCC-revaccinated children is 0.59 (95% CI 0.14 to 2.47) compared with the control group. The incidence of tuberculosis has continued to decline among adolescents since 1980. The follow-up data confirm that the cessation of BCG revaccination program had no effect on the continuing overall decline of tuberculosis in Finland. The efficacy of BCG revaccination seems to be low or nonexistent in countries with low tuberculosis incidence.
引用
收藏
页码:1324 / 1327
页数:4
相关论文
共 22 条
[1]   DOES THE PROTECTIVE EFFECT OF NEONATAL BCG CORRELATE WITH VACCINE-INDUCED TUBERCULIN REACTION [J].
ALKASSIMI, FA ;
ALHAJJAJ, MS ;
ALORAINEY, IO ;
BAMGBOYE, EA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1575-1578
[2]  
COLDITZ GA, 1995, PEDIATRICS, V96, P29
[3]  
Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6
[4]  
FINE PEM, 1989, REV INFECT DIS, V11, pS353
[5]   VARIATION IN PROTECTION BY BCG - IMPLICATIONS OF AND FOR HETEROLOGOUS IMMUNITY [J].
FINE, PEM .
LANCET, 1995, 346 (8986) :1339-1345
[6]  
Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR, P298
[7]  
Kubit S, 1983, Pediatr Pol, V58, P775
[8]   THEORETICAL AND METHODOLOGICAL ASPECTS OF BCG VACCINE FROM THE DISCOVERY OF CALMETTE AND GUERIN TO MOLECULAR-BIOLOGY - A REVIEW [J].
LUGOSI, L .
TUBERCLE AND LUNG DISEASE, 1992, 73 (05) :252-261
[9]  
MURRAY C, 1991, HLTH SECTOR PRIORITI
[10]   GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS - MORBIDITY AND MORTALITY OF A WORLDWIDE EPIDEMIC [J].
RAVIGLIONE, MC ;
SNIDER, DE ;
KOCHI, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (03) :220-226